In order to define predictive markers and possibly find suitable new targets for multimodal therapies, the purpose of this study is to investigate the role of FGF8, ALK, and EML4 in upfront resected ESCC [18,19]. Here, EML4 is linked to esophageal squamous cell carcinoma.